Methyl 3-(hydroxymethyl)-5-methoxybenzoate, 95.0%, 250mg

3-Methylpyridine-2(1H)-thione>98.0%(HPLC)(T)1g

DIHYDRORESVERATROL, 95%, 100mg

2,5-dioxopyrrolidin-1-yl 5-(4-(1,2,4,5-tetrazin-3-yl)benzylamino)-5-oxopentanoate, 98%, 1mg

TERT-BUTYL 3-(THIOPHEN-2-YL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

3'-O-(tert-butyldiMethylsilyl)-2'-deoxyadenosine, 98%, 1g

2,3-DICHLORO-N-(3-METHOXYPYRAZIN-2-YL)BENZENESULFONAMIDE, 95%, 10mg

4-aminobenzoic acid, min. 98.5%, for synthesis, 250 g, plastic packaging.

5-Chloro-2,3-dibromotoluene, 95.0%, 5g

Methyl 4-amino-2-fluoro-3-methylbenzoate, 97%, 5g

methyl 8-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylate, 98%, 1g

3-(2-Amino-ethyl)-5-(4-chloro-phenyl)-thiazolidine-2,4-dione;hydrochloride, 250mg

1,1,2,2-Tetrakis(4-(bromomethyl)phenyl)ethene, 98%, 250mg